Diethyldithiocarbamate Suppresses an NF-κB Dependent Metastatic Pathway in Cholangiocarcinoma Cells

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 7, 2013, Pages 4441-4446

  Srikoon, Pattaravadee ^a   Kariya, Ryusho ^a   Kudo, Eriko ^a   Goto, Hiroki ^a   Vaeteewoottacharn, Kulthida ^a,b   Taura, Manabu ^a   Wongkham, Sopit ^b   Okada, Seiji ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Adhesion; Cholangiocarcinoma; Diethyldithiocarbamate; Metastasis; Migration; NF B

Indexed keywords

CHELATING AGENT; DIETHYLDITHIOCARBAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA;

APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GENETICS; HUMAN; INTRAHEPATIC BILE DUCT; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING; WOUND HEALING;

APOPTOSIS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CHELATING AGENTS; CHOLANGIOCARCINOMA; DITIOCARB; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; WOUND HEALING;

EID: 84885443467     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.7.4441     Document Type: Article

References (34)

1. Aggarwal BB (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell, 6, 203-8.
2. Andrews NC, Faller DV (1991). A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res, 19, 2499.
3. Basseres DS, Baldwin AS (2006). Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene, 25, 6817-30.
4. Blechacz B, Komuta M, Roskams T, Gores GJ (2011). Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol, 8, 512-22.
5. Boberg KM, Schrumpf E (2004). Diagnosis and treatment of cholangiocarcinoma. Curr Gastroenterol Rep, 6, 52-9.
6. Charbel H, Al-Kawas FH (2012). Cholangiocarcinoma treatment. Curr Gastroenterol Rep, 14, 528-33.
7. Chen JZ, Zhu JH, Wang XX, et al (2004). Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol, 36, 233-9.
8. Chiang AC, Massague J (2008). Molecular basis of metastasis. N Engl J Med, 359, 2814-23.
9. Cho HJ, Lee TS, Park JB, et al (2007). Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J Biochem Mol Biol, 40, 1069-76.
10. Cvek B, Dvorak Z (2007). Targeting of nuclear factor-kappaB and proteasome by dithiocarbamate complexes with metals. Curr Pharm Des, 13, 3155-67.
11. Dasanu CA, Majumder S, Trikudanathan G (2011). Emerging pharmacotherapeutic strategies for cholangiocarcinoma. Expert Opin Pharmacother, 12, 1865-74.
12. Eneanya DI, Bianchine JR, Duran DO, Andresen BD (1981). The actions of metabolic fate of disulfiram. Annu Rev Pharmacol Toxicol, 21, 575-96.
13. Goto H, Kariya R, Shimamoto M, et al (2012). Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-kappaB pathway. Cancer Sci, 103, 775-81.
14. Hu XS, Du CQ, Yang L, Yao XY, Hu SJ (2010). Proteasome inhibitor MG132 suppresses number and function of endothelial progenitor cells: involvement of nitric oxide synthase inhibition. Int J Mol Med, 25, 385-92.
15. Janan M, Proungvitaya S, Limpaiboon T, Proungvitaya T, Roytrakul S, et al (2012). Serum adhesion molecule-1 (icam-1) as a potential prognostic marker for cholangiocarcinoma patients. Asian Pac J Cancer Prev, 13, 107-14.
16. Langeland BT, McKinley-McKee JS (1996). The effects of disulfiram on equine hepatic alcohol dehydrogenase and its efficiency against alcoholism: vinegar effect. Alcohol Alcohol, 31, 75-80.
17. Liang CC, Park AY, Guan JL (2007). In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc, 2, 329-33.
18. Lovborg H, Oberg F, Rickardson L, et al (2006). Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram. Int J Cancer, 118, 1577-80.
19. Margineanu E, Cotrutz CE, Cotrutz C (2008). Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis. Rev Med Chir Soc Med Nat Iasi, 112, 432-6.
20. Maruo Y, Gochi A, Kaihara A, et al (2002). ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer. Int J Cancer, 100, 486-90.
21. Matsuno T, Kariya R, Yano S, et al (2012). Diethyldithiocarbamate induces apoptosis in HHV-8-infected primary effusion lymphoma cells via inhibition of the NF-kappaB pathway. Int J Oncol, 40, 1071-8.
22. Murai R, Yoshida Y, Muraguchi T, et al (2010). A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasis-suppressing anticancer drugs. Oncotarget, 1, 252-64.
23. Pande V, Ramos MJ (2005). NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. Curr Med Chem, 12, 357-74.
24. Pang H, Chen D, Cui QC, Dou QP (2007). Sodium diethyldithiocarbamate, an AIDS progression inhibitor and a copper-binding compound, has proteasome-inhibitory and apoptosis-inducing activities in cancer cells. Int J Mol Med, 19, 809-16.
25. Rosette C, Roth RB, Oeth P, et al (2005). Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis, 26, 943-50.
26. Schurigt U, Stopfel N, Huckel M, et al (2005). Local expression of matrix metalloproteinases, cathepsins, and their inhibitors during the development of murine antigen-induced arthritis. Arthritis Res Ther, 7, 174-88.
27. Seubwai W, Vaeteewoottacharn K, Hiyoshi M, et al (2010). Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB. Cancer Sci, 101, 1590-5.
28. Shian SG, Kao YR, Wu FY, Wu CW (2003). Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram. Mol Pharmacol, 64, 1076-84.
29. Skrott Z, Cvek B (2012). Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells. Mini Rev Med Chem, 12, 1184-92.
30. Suh JJ, Pettinati HM, Kampman KM, O'Brien CP (2006). The status of disulfiram: a half of a century later. J Clin Psychopharmacol, 26, 290-302.
31. Tang X, Li J, Xin X, Geng M (2006). A new marine-derived sulfated polysaccharide from brown alga suppresses tumor metastasis both in vitro and in vivo. Cancer Biol Ther, 5, 1474-80.
32. Uthaisar K, Seubwai W, Srikoon P, Vaeteewoottacharn K, Sawanyawisuth K, et al (2012). Cepharanthine suppresses metastatic potential of human cholangiocarcinoma cell lines. Asian Pac J Cancer Prev, 13, 149-54.
33. Wang F, Zhai S, Liu X, et al (2011). A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells. Cancer Lett, 300, 87-95.
34. Zhang JJ, Xu ZM, Zhang CM, et al (2011). Pyrrolidine dithiocarbamate inhibits nuclear factor-kappaB pathway activation, and regulates adhesion, migration, invasion and apoptosis of endometriotic stromal cells. Mol Hum Reprod, 17, 175-81.